News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 05, 2022, 16:30 ET ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022...

May 05, 2022, 16:20 ET Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting

Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo® (collagenase...

May 02, 2022, 07:55 ET Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use...

Apr 20, 2022, 17:23 ET Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo

Endo International plc (NASDAQ: ENDP) today announced that the Tennessee Court of Appeals has reversed a trial court judge's order denying a motion...

Apr 12, 2022, 17:00 ET Endo to Announce First-Quarter 2022 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first–quarter 2022 financial results on May 5, 2022 and members of its senior management team ...

Mar 28, 2022, 07:30 ET Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials

Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping premixed Ephedrine Sulfate Injection...

Mar 03, 2022, 16:30 ET Endo Launches New Living Our Values Program to Recognize Outstanding Team Members

Endo International plc (NASDAQ: ENDP) today honored select team members from across the world who exemplify Endo's Values as part of its inaugural...
Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events

Mar 02, 2022, 09:15 ET Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events

Endo International plc (NASDAQ: ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of...

Feb 28, 2022, 16:15 ET ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced...

Feb 11, 2022, 07:30 ET Endo Comments on Default Judgment on Liability in Tennessee State Court

Endo International plc (NASDAQ: ENDP) today announced that it expects a Tennessee state court to issue an order granting plaintiffs' request for a...

Feb 07, 2022, 07:30 ET Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles

First and only manufacturer-prepared, FDA approved vasopressin in a premixed ready-to-use (RTU) format RTU format does not require diluting, or...

Jan 25, 2022, 17:00 ET Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth–quarter and full-year 2021 financial results on February 28, 2022 and members of its...

Jan 18, 2022, 07:00 ET Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health...

Jan 13, 2022, 07:30 ET Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism

Pharmacokinetic simulation modeling study predicted more frequent administration with shorter dosing intervals (8 weeks vs. 10 weeks) would reduce...

Jan 11, 2022, 07:00 ET Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development

Endo International plc (NASDAQ: ENDP) today announced the appointment of Dr. James P. Tursi as Executive Vice President, Global Research &...

Jan 10, 2022, 07:30 ET Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education Unfold

The campaign features real Dupuytren's contracture (DC) patients and aims to address patient complacency, correct myths and misinformation and...

Jan 04, 2022, 18:25 ET Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the...

Jan 04, 2022, 17:00 ET Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday,...

Dec 23, 2021, 14:19 ET Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc., Endo Health...

Dec 23, 2021, 06:00 ET Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI® (Cenobamate) in Canada

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK...

Dec 15, 2021, 10:23 ET Endo Announces Favorable Final Ruling in California State Court Opioid Trial

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that one of the first public nuisance cases filed against manufacturers of...

Nov 22, 2021, 10:53 ET Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data Presented at the American Society for Dermatologic Surgery's Annual Meeting

Endo International plc (NASDAQ:ENDP) announced today that data from clinical and non-clinical studies of Endo Aesthetics' Qwo® (collagenase...

Nov 18, 2021, 07:30 ET Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection

Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP,...

Nov 17, 2021, 07:30 ET Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Production of Critical Medicines

Endo International plc (NASDAQ: ENDP) (Endo) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a...

Nov 08, 2021, 07:30 ET Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP) Vials, Essential for COVID-19 Care

Endo International plc (NASDAQ: ENDP) today announced that its Par Sterile Products business will supply VASOSTRICT®, vasopressin injection, USP,...